Larvol Delta - AltruBio-Announces-Positive-Topline-Data-from-Phase-1-Trial-of-Immune-Checkpoint-Enhancer-ALTB268-for-the-Treatment-of-Ulcerative-Colitis

leiolizumab (ALTB-268) - AltruBio

https://www.globenewswire.com/news-release/2023/08/01/2715771/0/en/AltruBio-Announces-Positive-Topline-Data-from-Phase-1-Trial-of-Immune-Checkpoint-Enhancer-ALTB-268-for-the-Treatment-of-Ulcerative-Colitis.html

Aug 1, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next